Repatha (Evolocumab): PCSK9 Inhibitor for High LDL Cholesterol
Repatha represents the most powerful LDL-lowering approach available — a biologic injection that lowers "bad" cholesterol by 50–60% even in patients already on maximum statin therapy.
Check Repatha Savings Options
Most insured patients pay $0/month with the Repatha® manufacturer savings card. Find options at Rx.com.
What Is Repatha?
Repatha (evolocumab) is a fully human monoclonal antibody manufactured by Amgen that targets PCSK9 — proprotein convertase subtilisin/kexin type 9. It comes as a pre-filled autoinjector (SureClick) or pre-filled syringe. The SureClick delivers 140 mg every 2 weeks; the Pushtronex device delivers 420 mg once monthly for patients who prefer monthly dosing.
How PCSK9 Inhibitors Work
PCSK9 is a liver enzyme that destroys LDL receptors — the "docking stations" on liver cells that grab LDL cholesterol from the blood and clear it. More PCSK9 = fewer LDL receptors = higher blood LDL.
By blocking PCSK9, Repatha prevents LDL receptor degradation. More receptors remain on liver cells → more LDL is pulled out of the bloodstream → dramatically lower LDL levels. It is a conceptually elegant mechanism that works in addition to, and separately from, statins.
Who Qualifies for Repatha?
FDA-approved indications:
- Heterozygous familial hypercholesterolemia (HeFH) — inherited high LDL; adjunct to diet and maximally tolerated statin therapy
- Homozygous familial hypercholesterolemia (HoFH) — more severe inherited form
- Atherosclerotic cardiovascular disease (ASCVD) — patients with established CVD (prior heart attack, stroke, or PAD) who need further LDL reduction despite statins
- Statin intolerance — off-label use in patients who cannot tolerate statins and have high cardiovascular risk
📌 Insurance prior authorization
Repatha almost always requires prior authorization from insurance — your provider must document that you have tried and maximally tolerated statin therapy or have a genetic cholesterol disorder. Your cardiologist or primary care provider can submit the PA. Approval rates are high when the documentation is thorough.
What Results to Expect
- LDL reduction: 50–65% on top of statin therapy at therapeutic dose
- The FOURIER trial (27,564 patients with ASCVD): Repatha reduced major cardiovascular events (heart attack, stroke, CV death) by 15% over placebo on statin background therapy over 2.2 years
- LDL can often be reduced to 20–40 mg/dL — levels never achievable with oral medications alone
- LDL reduction visible within 4 weeks of starting
Cost and Savings Programs
💲 Most patients pay $0/month
Amgen offers a Repatha Copay Card that covers up to $5,000 per year for commercially insured patients — making monthly out-of-pocket costs $0–$35 for most. Uninsured patients can apply for the Amgen Safety Net Foundation which provides Repatha free of charge based on income. Call 1-844-REPATHA for assistance enrollment.
Frequently Asked Questions
How does Repatha compare to statins?
Statins (atorvastatin, rosuvastatin) reduce LDL by 30–50% through a different mechanism (blocking cholesterol synthesis). Repatha adds an additional 50–65% LDL reduction on top of statins. They complement each other — statins reduce cholesterol production; Repatha dramatically increases the liver's ability to clear LDL from blood. In patients with very high cardiovascular risk, combination therapy achieves LDL targets not possible with statins alone.
Are PCSK9 inhibitors safe long-term?
Yes — data from 5+ years of follow-up in clinical trials show no safety concerns from achieving very low LDL levels. There were early theoretical concerns about cognitive effects at very low LDL, but large trials found no impairment. Side effects are generally mild — injection site reactions are the most common. The benefit in cardiovascular risk reduction is well-documented.
Can Repatha be used instead of a statin?
In patients who cannot tolerate any statin (true statin intolerance — confirmed myopathy, or liver disease), Repatha alone significantly lowers LDL and cardiovascular risk. However, statins and Repatha are usually more effective together. The GAUSS-3 trial showed Repatha was well-tolerated in statin-intolerant patients and achieved substantial LDL reductions.
How do I self-inject Repatha with the SureClick autoinjector?
Remove from refrigerator 30–45 minutes before injection. Inspect — should be clear to slightly opalescent. Clean injection site (abdomen, thigh, or upper arm) with alcohol. Remove cap, press firmly against skin, click once. Hold for 10 seconds. Rotate injection sites with each dose. Full video instructions are available at Repatha's website and your pharmacy can demonstrate technique.
How much does Repatha cost without insurance?
Repatha's list price is approximately $500–$600 per month without insurance. For uninsured patients, the Amgen Safety Net Foundation provides free medication based on income. Compare savings options at /drug/repatha-sureclick.
Check Repatha Savings — Most Pay $0/Month
Use manufacturer savings programs to dramatically reduce Repatha costs. Find options at Rx.com.